top of page

Navigating the Bloodstream: Microrobotics for Precision Drug Delivery

  • Aug 3
  • 3 min read

Systemic treatments such as traditional chemotherapy, have long been one of the most prominent medical interventions in the 21st century. However, because these therapeutics flood the entire body to reach a target site, they inevitably interact with other healthy tissues and organs, which poses severe risks and limiting permissible dosages.

 

To improve targeting, modern medicine introduced nanoparticle therapeutics. Yet, even these carriers rely heavily on passive diffusion to reach the target. Studies had also found that only 1.48% and 0.70% per injected dose actually reaches the targeted tumor site, underscoring inefficiency in modern medicine (Cheng et al., 2020). Therefore, in order to achieve localized and high-precision treatment, researchers are turning towards nanotechnology and engineering to create microrobotics.

 

 

The Power of Microrobotics



Microrobots with nanoscale grippers (Ivanyi et al., 2024)

 

Both traditional drug delivery systems and passive nanoparticle carriers rely on passive diffusion through the bloodstream, which can be subjected to rapid clearance by the immune system. Due to the therapeutic itself having large concentrations of active pharmaceutical ingredients, this could put a heavy metabolic burden on the liver and kidneys (Hartridge, 2026) .

 

Microrobotics circumvents these issues as these untethered devices have the capability to actively navigate complex biological fluids, bypassing physiological barriers to deliver concentrated therapeutics directly to a localized area.

 

Mechanisms and Propulsion


Microrobots have three primary mechanisms that are utilized for navigating the human body:

 

Mechanism

Energy source

Propulsion method

Properties

Magnetic

External Magnetic fields

Magnetic stirrer and corkscrew rotation

Deep tissue penetration, real-time directional control

Biohybrid

Biological motile bacteria or cells (Sperm cells)

Cellular Flagellar movement

Highly biocompatible, ability to cross biological barriers, self powered.

Acoustic

Ultrasound

Acoustic streaming and cavitation

Fast movement and deep penetration with high precision.

(Wang et al., 2025)

 

After utilizing its propulsion mechanism to reach the target site, microrobots must execute a controlled release of the carried therapeutics. Which is activated by the attending physician. Once the microrobot is positioned correctly, acoustic waves cause the microrobot’s outer shell to rupture and release the drug. Which ensures the drug is deposited instantly and exclusively into the localized treatment area.

 

Challenges and Limitation


Despite its potential, several obstacles currently hinders the large-scale clinical application for drug delivering microrobots.

 

●      Biocompatibility: Materials used to manufacture synthetic microrobots must not only be non toxic, but also entirely biodegradable. If the body’s immune system identifies them as a foreign threat, it may trigger inflammatory responses that harms the patient. .

●      Complex fluid Dynamics: Making precise movements against viscous blood flow and locating these microscopic devices in real time tracking poses a massive challenge.

 

Future Prospects

 

Transitioning from systemic drug distribution to localized, robot-assisted targeted delivery represents a major shift in biomedical engineering. By utilizing the active propulsion and protective capabilities of these microscopic devices, we can tackle the systemic issue of off-target drug toxicity at its root. While optimization in real-time in vivo imaging and clinical standardization is still required, the marriage of micro-engineering and medicine promises a safer, more effective future for therapeutics.

 

 

Citations:

Cheng, Y.-H., He, C., Riviere, J. E., Monteiro-Riviere, N. A., & Lin, Z. (2020). Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach. ACS Nano, 14(3), 3075–3095. https://doi.org/10.1021/acsnano.9b08142

 

Hartridge, D. E. (2026). Advancements in Targeted Drug Delivery Systems: Current Trends and Future Perspectives. The Sankalpa: International Journal of Management Decisions, 12(1), 2269–2274. https://thesankalpa.org/ijmd/article/view/353

 

Ivanyi, G.T., Nemes, B., Grof, I., Fekete, T., Kubackova, J., Tomori, Z.,

Bano, G., Vizsnyiczai, G., and Kelemen, L. (2024). Optically Actuated

Soft Microrobot Family for Single-Cell Manipulation. Adv. Mater. 36,


Wang, T., Chen, Z., Huang, Q., Arai, T., & Liu, X. (2025). Advanced microrobots driven by acoustic and magnetic fields for biomedical applications. Cyborg and Bionic Systems. https://doi.org/10.34133/cbsystems.0386


This article was prepared by Chin Yu Xuan (Taylor's University).


 
 
 

Comments


Stay Up-To-Date with New Posts

Search By Tags

© the Malaysian Bioscience Scholars est. 2017

bottom of page